DNA Vaccine Market By Source (Humans, Animals, Others), by Technology (pDNA delivery technology, pDNA vaccines technology), by Application (Human diseases, Veterinary diseases), Industry Trends, Estimation & Forecast, 2017 - 2025
- Published Date: 2020-11-27
- Report ID: 22674
- Pages: 139
-
Format:
Dna Vaccine Market 2018-2026 report is a professional study on the current state of the market that focuses on the major drivers, challenges, opportunities for the leading players. The research report also offers a granular analysis of various definitions, and classification of the industry, applications of the industry, regional breakdown, opportunities, challenges, and chain structure.
About Dna Vaccine Market
DNA Vaccine Market is expected to grow with a CAGR of 40% during the forecast period of 2018 to 2025. Technological advancements in the medical sector have led to the advent of third generation vaccines such as DNA, viral/bacterial vectored, and autologous proteins. DNA vaccine is an emerging vaccine type having several benefits such as usage of multiple genes to enhance immunity, specific targeting, and low risk rates as compared to the traditional vaccines. The emergence of nouveau biotechnology and nanotechnology trends such as electroporation, novel molecular adjuvant technologies, and DNA prime-adenovector boost are fuelling the development rate of DNA vaccines.
Market Summary:
The Dna Vaccine market is a comprehensive report which offers a meticulous overview of the market share, size, trends, demand, product analysis, application analysis, regional outlook, competitive strategies, forecasts, and strategies impacting the Dna Vaccine Industry. The report includes a detailed analysis of the market competitive landscape, with the help of detailed business profiles, SWOT analysis, project feasibility analysis, and several other details about the key companies operating in the market.
The study on the worldwide Dna Vaccine market strives to offer substantial and profound insights into the current market scenario and the developing growth dynamics. Moreover, the report also provides the market players along with the new contenders a complete view of the market landscape. The inclusive research will enable the well-established as well as the entry-level players to establish their business strategies and accomplish their short-term and long-term goals.
Scope and Segmentation of the Report
The segment analysis is one of the significant sections of this report. Our expert analyst has categorized the market into product type, application/end-user, and geography. All the segments are analyzed based on their market share, growth rate, and growth potential. In the geographical classification, the report highlights the regional markets having high growth potential. This thorough evaluation of the segments would help the players to focus on revenue-generating areas of the Dna Vaccine market.
Based on Type
By Technology
pDNA delivery technology
pDNA vaccines technology
By Application
Human diseases
Veterinary diseases
Based on Application
Humans
Animals
Others
Regional Analysis
Our analysts are experts in covering all types of geographical markets from developing to mature ones. You can expect a comprehensive research analysis of key regional and country-level markets such as Europe, North America, South America, Asia-Pacific, and the Middle East & Africa. With accurate statistical patterns and regional classification, our domain experts provide you one of the most detailed and easily understandable regional analyses of the Dna Vaccine market.
Competitive Landscape:
The research report also studied the key players operating in the Dna Vaccine market. It has evaluated and explained the research & development stages of these companies, their financial performances, and their expansion plans for the coming years. Moreover, the research report also includes the list of planned initiatives that clearly explain the accomplishments of the companies in the recent past.
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products, etc.):
Vical Inc.
Novartis Animal Health
Inovio Biomedical Corp.
Dendreon Corporation
Astellas Pharma
Merck & Co.
GlaxoSmithKline Inc.
Sanofi
Xenetic Biosciences Inc.
Tekmira Pharmaceuticals
Indian Immunologicals Ltd
Pfizer Pharmaceuticals
Tolerion Inc.
QED Biosciences Inc.
Advance Bioscience Laboratories Inc.
Research Methodology
The research methodology of the market is based on both primary as well as secondary research data sources. It compels different factors affecting the Dna Vaccine industry such as historical data and market trends, different policies of the government, market environment, market risk factors, market restraints, technological advancements, forthcoming innovations, and obstacles in the industry.
The content of the study subjects includes a total of 8 chapters:
Chapter 1, describe the Dna Vaccine market reports executive summary, market definition, and market scope. Moreover, the report helps in picking up the crucial information about the said market.
Chapter 2, defines the Research Methodology including primary research, assumptions & exclusions, and secondary data sources. The report follows the simultaneous top-down and bottom approach to provide you the accurate market sizing.
Chapter 3, explains the report segmentation & scope, key market trends (drivers, restraints, and opportunities), along with Porters five forces analysis and market share analysis
Chapter 4: It helps in understanding the key product segments and their future of the Dna Vaccine Market. It provides strategic recommendations in key business segments based on the market estimations.
Chapters 5, and 6 to segment the sales by type and application/end-user, with sales market share and growth rate by type, application/end-user, from 2018 to 2016. Our team of Analysts and experts dedicatedly put their effort to provide you the best possible and accurate segmentation data and analysis.
Chapter 7, describes the regional segmentation based on the country level for the forecast period 2018 2026. The research report not only provide the market data of the five geographies but also provide the qualitative as well we qualitative information on country level bifurcation.
Chapter 8, to profile the top manufacturers of Dna Vaccine, with price, sales, revenue and market share of Dna Vaccine in 2016, 2017, and 2018. Players are expected to sign acquisition and collaboration deals to expand their products and services portfolio. Such strategic agreements could help them to improve their client base in other countries and gain a competitive advantage
CHAPTER 1. INTRODUCTION
1.1. RESEARCH METHODOLOGY
1.1.1. ERC desk research
1.1.2. ERC data synthesis
1.1.3. Data validation and market feedback
1.1.4. ERC data sources
CHAPTER 2. DNA VACCINE MARKET OVERVIEW
2.1. DNA VACCINE MARKET INTRODUCTION
2.2. GLOBAL DNA VACCINE MARKET PRODUCTION AND GROWTH RATE, 2017-2025
2.2.1. Global DNA Vaccine Production (VOLUME) and Growth Rate (%), (2017-2025)
2.3. GLOBAL DNA VACCINE MARKET CAPACITY AND GROWTH RATE, 2017-2025
2.3.1. Global DNA Vaccine Capacity (VOLUME) and Growth Rate (%), (2017-2025)
2.4. GLOBAL DNA VACCINE MARKET REVENUE AND GROWTH RATE, 2017-2025
2.4.1. Global DNA Vaccine Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
2.5. GLOBAL DNA VACCINE MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
2.5.1. Global DNA Vaccine Consumption (VOLUME) and Growth Rate (%), (2017-2025)
CHAPTER 3. GLOBAL DNA VACCINE MARKET BY SOURCE, 2017-2025
3.1. HUMANS
3.2. ANIMALS
3.3. OTHERS
3.4. GLOBAL DNA VACCINE MARKET REVENUE BY SOURCE, 2017-2025
3.4.1. Global DNA Vaccine Market Revenue (Million USD) and Share (%) By Source, 2017-2025
3.4.2. Humans Market Revenue and Growth Rate, 2017-2025
3.4.3. Animals Market Revenue and Growth Rate, 2017-2025
3.4.4. Others Market Revenue and Growth Rate, 2017-2025
3.5. GLOBAL DNA VACCINE MARKET PRODUCTION BY SOURCE, 2017-2025
3.5.1. Global DNA Vaccine Market Production (Volume) and Share (%) By Source, 2017-2025
3.5.2. Humans Market Production and Growth Rate, 2017-2025
3.5.3. Animals Market Production and Growth Rate, 2017-2025
3.5.4. Others Market Production and Growth Rate, 2017-2025
CHAPTER 4. GLOBAL DNA VACCINE MARKET BY APPLICATION, 2017-2025
4.1. HUMAN DISEASES
4.2. VETERINARY DISEASES
4.3. GLOBAL DNA VACCINE MARKET REVENUE BY APPLICATION, 2017-2025
4.3.1. Global DNA Vaccine Market Revenue (Million USD) and Share (%) By Application, 2017-2025
4.3.2. Human diseases Market Revenue and Growth Rate, 2017-2025
4.3.3. Veterinary diseases Market Revenue and Growth Rate, 2017-2025
4.4. GLOBAL DNA VACCINE MARKET CONSUMPTION BY APPLICATION, 2017-2025
4.4.1. Global DNA Vaccine Market Consumption (Volume) and share (%) By Application, 2017-2025
4.4.2. Human diseases Market Consumption and Growth Rate, 2017-2025
4.4.3. Veterinary diseases Market Consumption and Growth Rate, 2017-2025
CHAPTER 5. GLOBAL DNA VACCINE MARKET BY TECHNOLOGY, 2017-2025
5.1. PDNA DELIVERY TECHNOLOGY
5.2. PDNA VACCINES TECHNOLOGY
CHAPTER 6. GLOBAL DNA VACCINE MARKET BY REGION, 2017-2025
6.1. NORTH AMERICA
6.1.1. U.S.
6.1.2. Canada
6.1.3. Mexico
6.2. EUROPE
6.2.1. U.K.
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe
6.3. ASIA PACIFIC
6.3.1. China
6.3.2. Japan
6.3.3. India
6.3.4. Korea
6.3.5. Rest of APAC
6.4. SOUTH AMERICA
6.4.1. Brazil
6.4.2. Rest of South America
6.5. REST OF THE WORLD
6.5.1. Middle East
6.5.2. Africa
6.6. GLOBAL DNA VACCINE MARKET REVENUE BY REGION, 2017-2025
6.6.1. Global DNA Vaccine Market Revenue (Million USD) and Share (%) By Region, 2017-2025
6.6.2. North America Market Revenue and Growth Rate, 2017-2025
6.6.3. Europe Market Revenue and Growth Rate, 2017-2025
6.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
6.6.5. South America Market Revenue and Growth Rate, 2017-2025
6.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025
CHAPTER 7. GLOBAL DNA VACCINE MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
7.1. GLOBAL DNA VACCINE MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
7.1.1. Global DNA Vaccine Market Production (Volume) and Share (%) By Region, 2017-2025
7.1.2. Global DNA Vaccine Market Consumption (Volume) and Share (%) By Region, 2017-2025
7.1.3. North America Market Production and Consumption, 2017-2025
7.1.4. Europe Market Production and Consumption, 2017-2025
7.1.5. Asia Pacific Market Production and Consumption, 2017-2025
7.1.6. South America Market Production and Consumption, 2017-2025
7.1.7. Rest of the World Market Production and Consumption, 2017-2025
CHAPTER 8. MARKET DETERMINANTS
8.1. MARKET DRIVERS
8.2. MARKET RESTRAINTS
8.3. MARKET OPPORTUNITIES
8.4. MARKET DETERMINANTS RADAR CHART
CHAPTER 9. GLOBAL DNA VACCINE MARKET COMPETITION BY MANUFACTURERS
9.1. GLOBAL DNA VACCINE PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
9.1.1. Global DNA Vaccine Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
9.2. GLOBAL DNA VACCINE REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
9.2.1. Global DNA Vaccine Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
9.3. DNA VACCINE MARKET COMPETITIVE SITUATION AND TRENDS
9.3.1. DNA Vaccine Market Share (%) of Top 3 Manufacturers
9.3.2. DNA Vaccine Market Share (%) of Top 5 Manufacturers
CHAPTER 10. GLOBAL DNA VACCINE MANUFACTURERS ANALYSIS
10.1. VICAL INC.
10.1.1. Business Overview
10.1.2. Company Basic Information
10.1.3. DNA Vaccine Product Details
10.1.4. Vical Inc. DNA Vaccine Production, Revenue and Gross Margin
10.2. NOVARTIS ANIMAL HEALTH
10.2.1. Business Overview
10.2.2. Company Basic Information
10.2.3. DNA Vaccine Product Details
10.2.4. Novartis Animal Health DNA Vaccine Production, Revenue and Gross Margin
10.3. INOVIO BIOMEDICAL CORP.
10.3.1. Business Overview
10.3.2. Company Basic Information
10.3.3. DNA Vaccine Product Details
10.3.4. Inovio Biomedical Corp. DNA Vaccine Production, Revenue and Gross Margin
10.4. DENDREON CORPORATION
10.4.1. Business Overview
10.4.2. Company Basic Information
10.4.3. DNA Vaccine Product Details
10.4.4. Dendreon Corporation DNA Vaccine Production, Revenue and Gross Margin
10.5. ASTELLAS PHARMA
10.5.1. Business Overview
10.5.2. Company Basic Information
10.5.3. DNA Vaccine Product Details
10.5.4. Astellas Pharma DNA Vaccine Production, Revenue and Gross Margin
10.6. MERCK & CO.
10.6.1. Business Overview
10.6.2. Company Basic Information
10.6.3. DNA Vaccine Product Details
10.6.4. Merck & Co. DNA Vaccine Production, Revenue and Gross Margin
10.7. GLAXOSMITHKLINE INC.
10.7.1. Business Overview
10.7.2. Company Basic Information
10.7.3. DNA Vaccine Product Details
10.7.4. GlaxoSmithKline Inc. DNA Vaccine Production, Revenue and Gross Margin
10.8. SANOFI
10.8.1. Business Overview
10.8.2. Company Basic Information
10.8.3. DNA Vaccine Product Details
10.8.4. Sanofi DNA Vaccine Production, Revenue and Gross Margin
10.9. XENETIC BIOSCIENCES INC.
10.9.1. Business Overview
10.9.2. Company Basic Information
10.9.3. DNA Vaccine Product Details
10.9.4. Xenetic Biosciences Inc. DNA Vaccine Production, Revenue and Gross Margin
10.10. TEKMIRA PHARMACEUTICALS
10.10.1. Business Overview
10.10.2. Company Basic Information
10.10.3. DNA Vaccine Product Details
10.10.4. Tekmira Pharmaceuticals DNA Vaccine Production, Revenue and Gross Margin
CHAPTER 11. DNA VACCINE MARKET VALUE CHAIN ANALYSIS
11.1. DNA VACCINE INDUSTRIAL CHAIN ANALYSIS
11.2. DNA VACCINE KEY RAW MATERIALS ANALYSIS
11.2.1. Key Raw Materials
11.2.2. Price Trend of Key Raw Materials
11.2.3. Key Suppliers of Raw Materials
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
